Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?

Ewer MS, Lenihan DJ.

J Clin Oncol. 2008 Mar 10;26(8):1201-3. doi: 10.1200/JCO.2007.14.8742. Epub 2008 Jan 28. No abstract available.

2.

Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.

Feola M, Garrone O, Occelli M, Francini A, Biggi A, Visconti G, Albrile F, Bobbio M, Merlano M.

Int J Cardiol. 2011 Apr 14;148(2):194-8. doi: 10.1016/j.ijcard.2009.09.564. Epub 2009 Nov 27.

PMID:
19945181
3.

Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.

Coccaro M, Gallucci G.

J Clin Oncol. 2008 Jul 1;26(19):3288; author reply 3289. doi: 10.1200/JCO.2008.17.3203. No abstract available.

4.

Cardiac dysfunction in cancer patients receiving paclitaxel.

Valdés Olmos RA, ten Bokkel Huinink WW, Hoefnagel CA.

Eur J Nucl Med. 1998 Apr;25(4):446-7. No abstract available.

PMID:
9643974
5.

Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.

Ganz PA, Hussey MA, Moinpour CM, Unger JM, Hutchins LF, Dakhil SR, Giguere JK, Goodwin JW, Martino S, Albain KS.

J Clin Oncol. 2008 Mar 10;26(8):1223-30. doi: 10.1200/JCO.2007.11.8877. Epub 2008 Jan 28.

6.

Cardiotoxicity of trastuzumab in clinical practice.

McArthur HL, Chia S.

N Engl J Med. 2007 Jul 5;357(1):94-5. No abstract available.

7.

Troponin I, cardiac ventricular dysfunction and causal toxicity of chemotherapy drugs.

Delval L.

Ann Oncol. 2002 Dec;13(12):1952-3; author reply 1953. No abstract available.

8.

Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough.

Eidem BW.

J Am Soc Echocardiogr. 2008 Dec;21(12):1290-2. doi: 10.1016/j.echo.2008.10.008. No abstract available.

PMID:
19041570
9.

New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.

Ryberg M, Nielsen D, Cortese G, Nielsen G, Skovsgaard T, Andersen PK.

J Natl Cancer Inst. 2008 Aug 6;100(15):1058-67. doi: 10.1093/jnci/djn206. Epub 2008 Jul 29.

10.

Anthracycline cardiotoxicity: one size does not fit all!

Hershman DL, Neugut AI.

J Natl Cancer Inst. 2008 Aug 6;100(15):1046-7. doi: 10.1093/jnci/djn241. Epub 2008 Jul 29. No abstract available.

11.

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate.

Telli ML, Witteles RM, Fisher GA, Srinivas S.

Ann Oncol. 2008 Sep;19(9):1613-8. doi: 10.1093/annonc/mdn168. Epub 2008 Apr 23.

12.

Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting: a 10-year single institution experience.

Testore F, Milanese S, Ceste M, de Conciliis E, Parello G, Lanfranco C, Manfredi R, Ferrero G, Simoni C, Miglietta L, Ferro S, Giaretto L, Bosso G.

Am J Cardiovasc Drugs. 2008;8(4):257-63.

PMID:
18690759
13.

The heart of the matter.

Portera CC, Swain SM.

J Clin Oncol. 2007 Sep 1;25(25):3794-6. Epub 2007 Jul 30. No abstract available.

14.

Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma.

Kilickap S, Yavuz B, Aksoy S, Sahiner L, Dincer M, Harputluoglu H, Erman M, Aytemir K, Tokgozoglu L, Barista I.

Med Oncol. 2008;25(4):437-42. doi: 10.1007/s12032-008-9062-2. Epub 2008 Apr 15.

PMID:
18415035
15.

[Cardiotoxicity of doxorubicin in children].

Pilon JW, Naeff MS, Taminiau JA.

Ned Tijdschr Geneeskd. 1984 Jul 14;128(28):1339-43. Dutch. No abstract available.

PMID:
6482993
16.

Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.

Chen C, Heusch A, Donner B, Janssen G, Göbel U, Schmidt KG.

Klin Padiatr. 2009 May-Jun;221(3):162-6. doi: 10.1055/s-0029-120722. Epub 2009 May 12.

PMID:
19437364
17.

Comment on 'Chemotherapy for testicular cancer induces acute alterations in diastolic heart function'.

Dieckmann KP.

Br J Cancer. 2014 Jan 7;110(1):264-5. doi: 10.1038/bjc.2013.703. Epub 2013 Nov 7. No abstract available.

18.

Reply: Comment on 'Chemotherapy for testicular cancer induces acute alterations in diastolic heart function'.

van Schinkel LD, Willemse PM, van der Meer RW, Burggraaf J, van Elderen SG, Smit JW, de Roos A, Osanto S, Lamb HJ.

Br J Cancer. 2014 Jan 7;110(1):265. doi: 10.1038/bjc.2013.704. Epub 2013 Nov 7. No abstract available.

20.

Reply to V. Pitini et al.

Mayer EL, Lin NU.

J Clin Oncol. 2013 Jun 10;31(17):2225-6. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk